Brassica Pharma Private Limited, a active private limited company, was established on 27 February 2006 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2006PTC160053. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹5.76 Cr.
It upholds a compliant status. Employing 153 professional, Its leadership includes Uday Suresh Chile (Director), Jayashree Manohar Sirsavkar (Director). Past directors included Manohar Dattatraya Sirsavkar. It holds ₹15.09 Cr open charges and ₹34.94 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at 701/702,7Th Floor Vastubh Apartment Off Road To Carter Road No 1,Nr. Subway,, Borivli E, Mumbai, Maharashtra, 400066.
U24230MH2006PTC160053
160053
27 February 2006
₹7.50 Cr
₹5.76 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Brassica Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uday Suresh Chile | Director | 27 Feb 2006 | Current |
| Jayashree Manohar Sirsavkar | Director | 27 Feb 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Brassica Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 34.98% increase. The company also saw a substantial improvement in profitability, with a 66.05% increase in profit. The company's net worth moved up by a moderate rise of 3.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Brassica Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹150,860,000.00
₹349,403,258.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2024 | Axis Bank Limited | ₹15.00 Cr | Open |
| 31 Mar 2023 | Others | ₹0.86 M | Open |
| 07 Jan 2022 | Abhyudaya Co-Operative Bank Limited | ₹1.50 Cr | Satisfied |
| 12 Oct 2020 | Abhyudaya Co-Operative Bank Limited | ₹4.50 M | Satisfied |
| 25 Sep 2020 | Abhyudaya Co-Operative Bank Limited | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Brassica Pharma has a workforce of 153 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Brassica Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brassica Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Brassica Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
A charge registered on 07 Jan 2022 via Charge ID 100525017 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 28 Jun 2024. was recorded as a recent event.
Progress on A charge registered on 23 Sep 2015 via Charge ID 10595711 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 28 Jun 2024. was documented.
Progress on A charge registered on 12 Jul 2012 via Charge ID 10371153 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 28 Jun 2024. was documented.
The activity A charge registered on 22 Feb 2012 via Charge ID 10345221 with Abhyudaya Co-Op. Bank Ltd was fully satisfied on 28 Jun 2024. was completed.
Progress on A charge registered on 22 Feb 2012 via Charge ID 10345225 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 28 Jun 2024. was documented.
The CIN of Brassica Pharma Private Limited is U24230MH2006PTC160053.
Brassica Pharma Private Limited is headquartered at 701/702,7Th Floor Vastubh Apartment Off Road To Carter Road No 1,Nr. Subway,, Borivli E, Mumbai, Maharashtra, 400066.
Brassica Pharma Private Limited was incorporated on 27 February 2006.
The current directors of Brassica Pharma Private Limited are
The primary industry of Brassica Pharma Private Limited is Manufacturing.
Brassica Pharma Private Limited is unlisted.
The authorized capital of Brassica Pharma Private Limited is ₹7.50 Cr, and the paid-up capital is ₹5.76 Cr.
The compliance status of Brassica Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX